rs7483
Orientation | minus |
Stabilized | minus |
Make rs7483(A;A) |
Make rs7483(A;G) |
Make rs7483(G;G) |
Reference | GRCh38 38.1/142 |
Chromosome | 1 |
Position | 109737079 |
Gene | GSTM3 |
is a | snp |
is | mentioned by |
dbSNP | rs7483 |
dbSNP (classic) | rs7483 |
ClinGen | rs7483 |
ebi | rs7483 |
HLI | rs7483 |
Exac | rs7483 |
Gnomad | rs7483 |
Varsome | rs7483 |
LitVar | rs7483 |
Map | rs7483 |
PheGenI | rs7483 |
Biobank | rs7483 |
1000 genomes | rs7483 |
hgdp | rs7483 |
ensembl | rs7483 |
geneview | rs7483 |
scholar | rs7483 |
rs7483 | |
pharmgkb | rs7483 |
gwascentral | rs7483 |
openSNP | rs7483 |
23andMe | rs7483 |
SNPshot | rs7483 |
SNPdbe | rs7483 |
MSV3d | rs7483 |
GWAS Ctlg | rs7483 |
GMAF | 0.3806 |
Max Magnitude | 0 |
? | (A;A) (A;G) (G;G) | 28 |
---|---|---|
|
[PMID 18423940] association of the rs7483 SNP with late-onset Alzheimer's disease
[PMID 19696791] Association between polymorphisms in glutathione S-transferase Mu3 and IgG titer levels in serum against Helicobacter pylori
[PMID 16112301] NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
[PMID 17601350] A genetic association analysis of cognitive ability and cognitive ageing using 325 markers for 109 genes associated with oxidative stress or cognition.
[PMID 17904251] Gene variations in GSTM3 are a risk factor for Alzheimer's disease.
[PMID 19151192] Variation in the GST mu locus and tobacco smoke exposure as determinants of childhood lung function.
[PMID 19223546] Xenobiotic metabolizing gene variants, dietary heterocyclic amine intake, and risk of prostate cancer.
[PMID 21799460] HapMap-based study of human soluble glutathione S-transferase enzymes: the role of natural selection in shaping the single nucleotide polymorphism diversity of xenobiotic-metabolizing genes.
[PMID 23036584] Discovery by the Epistasis Project of an epistatic interaction between the GSTM3 gene and the HHEX/IDE/KIF11 locus in the risk of Alzheimer's disease
[PMID 24157827] Genetic variation in the GSTM3 promoter confer risk and prognosis of renal cell carcinoma by reducing gene expression